XML 45 R33.htm IDEA: XBRL DOCUMENT v3.20.2
Earnings per Share (Tables)
 6 Months Ended
Jun. 30, 2020
Earnings Per Share [Abstract]  
Components of basic and diluted earnings per share
The following table sets forth the components of basic and diluted EPS ($ in thousands, except per share):

Three months ended June 30, 2020Three months ended June 30, 2019
Income
(Numerator)		Shares
(Denominator)		Per Share
Amount		Income
(Numerator)		Shares
(Denominator)		Per Share
Amount
Basic EPS
Consolidated net income attributable to common stockholders$6,242  22,808,943  $13,027  19,169,941  
Allocation of earnings to participating restricted shares(33) —  (133) —  
Consolidated net income attributable to unrestricted common stockholders$6,209  22,808,943  $0.27  $12,894  19,169,941  $0.67  
Effect of dilutive securities(1)
Operating Partnership units—  —  107  349,774  
Restricted stock grants and Manager and director fee shares(2)
33  120,906  —  —  
Interest expense (add back) and assumed conversion of shares from convertible senior notes(3)
—  —  2,545  8,212,872  
Diluted EPS
Consolidated net income attributable to common stockholders and dilutive securities$6,242  22,929,849  $0.27  $15,546  27,732,587  $0.56  

(1)The Company's outstanding warrants for an additional 6,500,000 shares of common stock would have an antidilutive effect on diluted earnings per share for the quarter ended June 30, 2020, and have not been included in the calculation.
(2)The effect of restricted stock grants and manager and director fee shares on the Company's diluted EPS calculation for June 30, 2019 would have been anti-dilutive and have been removed from the calculation.
(3)The effect of the interest expense and assumed conversion of shares from convertible senior notes on the Company's Diluted EPS calculation for the first quarter of 2020 would have been anti-dilutive, accordingly the effect of these securities have been removed from the Diluted EPS calculation for the quarter ended June 30, 2020.
Six months ended June 30, 2020Six months ended June 30, 2019
Income
(Numerator)		Shares
(Denominator)		Per Share
Amount		Income
(Numerator)		Shares
(Denominator)		Per Share
Amount
Basic EPS
Consolidated net income attributable to common stockholders$6,642  22,439,648  $20,357  18,991,817  
Allocation of earnings to participating restricted shares(35) —  (221) —  
Consolidated net income attributable to unrestricted common stockholders$6,607  22,439,648  $0.29  $20,136  18,991,817  $1.06  
Effect of dilutive securities(1)
Operating Partnership units—  —  346  486,182  
Restricted stock grants and Manager and director fee shares(2)
35  120,268  219  206,916  
Interest expense (add back) and assumed conversion of shares from convertible senior notes(3)
—  —  5,093  8,194,693  
Diluted EPS
Consolidated net income attributable to common stockholders and dilutive securities$6,642  22,559,916  $0.29  $25,794  27,879,608  $0.93  

(1)The Company's outstanding warrants for an additional 6,500,000 shares of common stock would have an antidilutive effect on diluted earnings per share for the quarter ended June 30, 2020, and have not been included in the calculation.
(2)The effect of restricted stock grants and manager and director fee shares on the Company's diluted EPS calculation for June 30, 2019 would have been anti-dilutive and have been removed from the calculation.
(3)The effect of the interest expense and assumed conversion of shares from convertible senior notes on the Company's Diluted EPS calculation for the first quarter of 2020 would have been anti-dilutive, accordingly the effect of these securities have been removed from the Diluted EPS calculation for the quarter ended June 30, 2020.